Outcome After Ischaemic Stroke in Childhood
Overview
Affiliations
A parental questionnaire was used to investigate the outcome for children who had had ischaemic stroke, who were seen at Great Ormond Street Hospital, London between 1990 and 1996. The results of functional assessments carried out by a physiotherapist and an occupational therapist, and of quantitative evaluations carried out by a neuropsychologist were used for validation where possible. The relationship between clinical and radiological factors and outcome were examined. The children were aged between 3 months and 15 years at the time of stroke (median age 5 years) and the period of follow-up ranged from 3 months to 13 years (median duration 3 years). Of the 90 children for whom data were obtained, 13 (14%) had no residual impairments. Outcome was good in 37 children (40%) and poor in 53 (60%) (defined according to whether impairments interfered with daily life). Agreement, as measured by Cohen's kappa, was good or very good between the parents' responses and the qualitative measures provided by the medical professionals and the therapists, but only fair to moderate for the quantitative measures provided by the neuropsychologists. This may reflect different parental perceptions of the physical and cognitive aspects of outcome. Younger age at time of the stroke was the only significant predictor of adverse outcome.
Ronan V Front Pediatr. 2025; 12:1499330.
PMID: 39902230 PMC: 11788388. DOI: 10.3389/fped.2024.1499330.
A Review of Current Perspectives on Motoric Insufficiency Rehabilitation following Pediatric Stroke.
Colovic H, Zlatanovic D, Zivkovic V, Jankovic M, Radosavljevic N, Ducic S Healthcare (Basel). 2024; 12(2).
PMID: 38255037 PMC: 10815565. DOI: 10.3390/healthcare12020149.
Post-traumatic ischaemic stroke in a teenager after head trauma: A case report.
DAntini D, Perrotta F Trauma Case Rep. 2023; 45:100835.
PMID: 37206626 PMC: 10189456. DOI: 10.1016/j.tcr.2023.100835.
Advances in the Diagnosis and Treatment of Pediatric Arterial Ischemic Stroke.
Sun L, Lynch J Neurotherapeutics. 2023; 20(3):633-654.
PMID: 37072548 PMC: 10112833. DOI: 10.1007/s13311-023-01373-5.
Delatorre R, Sutter E, Nemanich S, Krach L, Meekins G, Feyma T Dev Neurorehabil. 2023; 26(3):216-221.
PMID: 36967533 PMC: 10228174. DOI: 10.1080/17518423.2023.2193626.